Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-006384
Filing Date
2017-01-31
Accepted
2017-01-31 16:28:53
Documents
1
Period of Report
2017-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7569
  Complete submission text file 0001209191-17-006384.txt   8884
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35966 | Film No.: 17561482

Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 339-499-9300
bluebird bio, Inc. (Issuer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)